SCHEMBL19744548

SCHEMBL19744548

NC(=O)C(O)C(N)CCCCNC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 2/20 0.39
GNAI3 P08754 1/20 0.37
GNAO1 P09471 1/20 0.37
GNAI1 P63096 1/20 0.37
OTC P00480 1/20 0.35
DDAH1 O94760 2/20 0.33
GSR P00390 1/20 0.33
ANPEP P15144 1/20 0.33
DNPEP Q9ULA0 1/20 0.33
RRM1 P23921 1/20 0.33
METAP2 P50579 1/20 0.32
SIRT5 Q9NXA8 1/20 0.32
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
NOS2 P35228 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
ARG1 P05089 3/20 0.31
ARG2 P78540 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19745098 0.98 DPP7 (0.38) DPP7GNAI3GNAO1GNAI1OTC
Benzene SCHEMBL28286275 0.92 DPP7 (0.37) DPP7GNAI3GNAO1GNAI1DDAH1
SCHEMBL20168406 0.83 DPP7 (0.46) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL20168409 0.83 DPP7 (0.46) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL19748369 0.79 DPP7 (0.33) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL19748366 0.79 DPP7 (0.33) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL13731193 0.79 DPP7 (0.40) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL20951925 0.77 OTC (0.46) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL20643482 0.77 GSR (0.57) DPP7GNAI3GNAO1GNAI1OTC
SCHEMBL357483 0.77 GSR (0.57) DPP7GNAI3GNAO1GNAI1OTC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472130-B1 ALIPHATIC PROLINAMIDE DERIVATIVES Orion Ophthalmology LLC (US) 2022-02-16 EP disclosed
US-10730832-B2 Aliphatic prolinamide derivatives Orion Ophthalmology LLC (US) 2020-08-04 US disclosed
US-20190330146-A1 ALIPHATIC PROLINAMIDE DERIVATIVES Orion Ophthalmology LLC (US) 2019-10-31 US disclosed
EP-3472130-A1 ALIPHATIC PROLINAMIDE DERIVATIVES ORION OPTHALMOLOGY LLC (US) 2019-04-24 EP disclosed
WO-2017222917-A1 ALIPHATIC PROLINAMIDE DERIVATIVES INCEPTION 4, INC. (US) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730832-B2 Aliphatic prolinamide derivatives HTRA1, ALDH1A2, PREP DPP7 49/4885GNAI3 2567/4885GNAO1 2413/4885
US-20190330146-A1 ALIPHATIC PROLINAMIDE DERIVATIVES HTRA1, ALDH1A2, PREP DPP7 49/4885GNAI3 2567/4885GNAO1 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.